KMPH KemPharm Inc.

+0.09  (+5%)
Previous Close 1.86
Open 1.94
Price To Book -0.74
Market Cap 55,649,630
Shares 28,519,259
Volume 27,324
Short Ratio
Av. Daily Volume 176,910

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1 complete. NDA filing due 2020.
KP511/IR 511/ER
Severe pain
NDA filing potentially due 2019.
Acute pain
NDA filing due late-2Q or early-3Q 2019.
CRL issued June 13, 2016. Resubmitted, and issued FDA Approval February 23, 2018.
Apadaz (KP201/APAP)
Acute pain
NDA filing planned for 2020.

Latest News

  1. KemPharm Reports First Quarter 2019 Results
  2. KemPharm Completes KP415 Pre-NDA Meeting with FDA
  3. Edited Transcript of KMPH earnings conference call or presentation 28-Feb-19 9:30pm GMT
  4. KemPharm Provides Update on APADAZ® Formulary Adoption
  5. Loss-Making KemPharm, Inc. (NASDAQ:KMPH) Expected To Breakeven
  6. KemPharm to Present at Upcoming Investor Conferences
  7. KemPharm Reports Q4 and FY 2018 Results
  8. KemPharm, Inc. to Host Earnings Call
  9. KemPharm to Report Fourth Quarter and Year End 2018 Results
  10. KemPharm Announces Enhancements to U.S. and Global Intellectual Property Estate
  11. What You Must Know About KemPharm, Inc.’s (NASDAQ:KMPH) Beta Value
  12. KemPharm Presenting Four Scientific Posters at APSARD's 2019 Annual Meeting
  13. KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of APADAZ® (4.08 mg benzhydrocodone/325 mg APAP and 8.16 mg benzhydrocodone/325 mg APAP)
  14. New Research: Key Drivers of Growth for Hewlett Packard Enterprise, Micron Technology, Cirrus Logic, Applied Genetic Technologies, KemPharm, and Communications — Factors of Influence, Major Initiatives and Sustained Production
  15. KemPharm Provides Corporate Update on Partnering Process for ADHD Prodrug Portfolio
  16. KemPharm Presents Poster at ACNP’s 57th Annual Meeting Highlighting the Intravenous Abuse Potential of Serdexmethylphenidate (SDX)
  17. KemPharm Webcast on Now Available for On-Demand Viewing
  18. Live Investor Conference & Webinar: NYSE, NASDAQ, and OTC companies present December 6th
  19. KemPharm to Webcast Live at on December 6th
  20. What Kind Of Shareholders Own KemPharm Inc (NASDAQ:KMPH)?